February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Highlights from BSMO25
Feb 3, 2025, 11:15

Highlights from BSMO25

The 27th Annual Belgian Society of Medical Oncology (BSMO) Meeting 2025 took place in Bruges from Friday 31st January to Saturday 1st February 2025.

BSMO

Here are a few highlights from the meeting:

BSMO:

“Our president, Evandro de Azambuja revealed the new BSMO logo, highlighting its focus on patient care, research and education.”

BSMO

Evandro de Azambuja:

“Which vaccines are recommended for oncological patients? Marie-Angélique De Scheerder.

BSMO

Elisa Agostinetto:

It has been a pleasure to present the results of our translational research project on lobular breast cancer awarded with a Gilead Sciences grant at BSMO25 in the beautiful Bruges. Thanks to Evandro de Azambuja and all amazing colleagues and friends.”

BSMO

Mariana Brandao:

Brilliant talk by Professor Martine Piccart on the evolution of clinical trials and translational research in oncology over the last decades. In order to serve our patients, academia has to evolve fast and come out with innovative and collaborative strategies!”

BSMO

Michail Ignatiadis:

“Excellent overview of treatment options post CDK4/6i by Andrea Gombos at the 2025 annual meeting of BSMO.” ⁦

BSMO

Anouk Goudsmit:

Louis Wolff, internist from Jules Bordet Institute is now on the stage of the 27th annual meeting of BSMO to present us cases of acquired hemophilia due to ICI. Thanks for this wonderful review of cases.”

BSMO

Evandro de Azambuja

Congratulations to Elisa Agostinetto for her 2022 Gilead Sciences award.”

BSMO

Mariana Brandao:

The large and dynamic Jules Bordet family at the BSMO Annual meeting at the beautiful city of Bruges. Thank you to Evandro de Azambuja and all the organization for such a wonderful Congress!”

BSMO

Anouk Goudsmit:

What a beautiful presentation by Mireille Langouo about “Lymphocyte Subpopulation Balances as a Blood Biomarker for Immune-Related Adverse Events in Patients Receiving Immune Checkpoint Inhibitor”.  A study conducted by Jules Bordet Institute.

BSMO

BSMO:

Professor Martine Piccart is opening the Young Oncologist Session at the BSMO 27th annual meeting. Her wonderful experience in clinical studies will help young oncologists to imagine their own!”

BSMO

Evandro de Azambuja:

Congratulations to Pierre Foidart for the Gilead Sciences.”

BSMO

Luca Arecco:

Two amazing days in magnificent Bruges for BSMO annual meeting led by Evandro de Azambuja. Great to hear again Matteo Lambertini and follow his inspiring lecture on how to treat young women with breast cancer.”

BSMO